Why the study?
Does oral dipyridamole reduce complications or deaths in patients with acute myocardial infarction?
Does oral dipyridamole reduce complications or deaths in patients with acute myocardial infarction?
Oral dipyridamole provides no clinical benefit in reducing complications or deaths in patients with acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Oral dipyridamole adds no value in acute MI; confirms lack of benefit on complications or death in this RCT.
A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups. It is concluded that dipyridamole has no benefit in acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Gent et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: